Royalty Pharma plc (RPRX) insider trading
Every open-market stock purchase and sale by Royalty Pharma plc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Christopher Hite (Chair) and 2 others sold $12.7M in the last 90 days.
- Last insider buy: Pablo G. Legorreta (CEO), $3.8M, 3 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $84.7M (35 sales). Last close $58.21 on Sep 25, 2026.
Recent RPRX insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 30, 2026 | Bonnie L Bassler (Director) | Bought (not open market) | $37.5K |
| Sep 28, 2026 | Marshall Urist (VP) | Sold | $239K |
| Sep 22, 2026 | Christopher Hite (Chair) | Sold | $5.6M |
| Sep 22, 2026 | Christopher Hite (Chair) | Sold | $231K |
| Aug 19, 2026 | Christopher Hite (Chair) | Sold (not open market) | — |
| Aug 18, 2026 | Christopher Hite (Chair) | Sold | $6M |
| Aug 13, 2026 | Terrance P. Coyne (CFO) | Sold | $541K |
| Aug 13, 2026 | Terrance P. Coyne (CFO) | Sold | $105K |
| Aug 7, 2026 | Marshall Urist (VP) | Sold (not open market) | — |
| Aug 7, 2026 | Terrance P. Coyne (CFO) | Sold (not open market) | — |
| Aug 7, 2026 | Pablo G. Legorreta (CEO) | Sold (not open market) | — |
| Aug 5, 2026 | Christopher Hite (Chair) | Bought (not open market) | — |
| Aug 5, 2026 | Marshall Urist (VP) | Bought (not open market) | — |
| Aug 5, 2026 | Pablo G. Legorreta (CEO) | Bought (not open market) | — |
| Aug 5, 2026 | Terrance P. Coyne (CFO) | Bought (not open market) | — |
| Jun 30, 2026 | Bonnie L Bassler (Director) | Bought (not open market) | $37.5K |
| Jun 24, 2026 | Marshall Urist (VP) | Sold | $502K |
| Jun 23, 2026 | Christopher Hite (Chair) | Sold | $6.4M |
| Jun 23, 2026 | Christopher Hite (Chair) | Sold | $1.8M |
| Jun 5, 2026 | Gregory Norden (Director) | Bought (not open market) | — |
| Jun 5, 2026 | Catherine M. Engelbert (Director) | Bought (not open market) | — |
| Jun 5, 2026 | Vlad Coric (Director) | Bought (not open market) | — |
| Jun 5, 2026 | Carole Ho (Director) | Bought (not open market) | — |
| Jun 5, 2026 | David C Hodgson (Director) | Bought (not open market) | — |
| Jun 5, 2026 | Elizabeth H Weatherman (Director) | Bought (not open market) | — |
Who's trading RPRX
- Bonnie L Bassler, Director: other filings, last Sep 30, 2026
- Marshall Urist, VP: sold $11.8M (16 sales), last Sep 28, 2026
- Christopher Hite, Chair: sold $20M (5 sales), last Sep 22, 2026
- Terrance P. Coyne, CFO: sold $39M (35 sales), last Aug 13, 2026
- Pablo G. Legorreta, CEO: other filings, last Aug 7, 2026
- Ted W Love, Director: other filings, last Jun 5, 2026
- Elizabeth H Weatherman, Director: other filings, last Jun 5, 2026
- Vlad Coric, Director: other filings, last Jun 5, 2026
- Catherine M. Engelbert, Director: other filings, last Jun 5, 2026
- David C Hodgson, Director: other filings, last Jun 5, 2026
- Carole Ho, Director: other filings, last Jun 5, 2026
- Gregory Norden, Director: sold $161K (1 sale), last Jun 5, 2026
- George W. Lloyd, C-suite exec: sold $13.8M (11 sales), last Dec 18, 2025
Get free alerts when an insider at Royalty Pharma plc files a new trade →